Alternative Conditioning Regimens Incorporating Bortezomib (Bor) or Carmustine (car) with High-Dose Melphalan (HDM) are Safe and Effective for Multiple Myeloma Patients (pts) Receiving a Second Autologous Stem Cell Transplant (AutoSCT)

Amanda N. Seddon; Anish Laul; Udit Yadav; Kathryn Schultz; John Maciejewski; Sunita Nathan

首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Alternative Conditioning Regimens Incorporating Bortezomib (Bor) or Carmustine (car) with High-Dose Melphalan (HDM) are Safe and Effective for Multiple Myeloma Patients (pts) Receiving a Second Autologous Stem Cell Transplant (AutoSCT)

【24h】

Alternative Conditioning Regimens Incorporating Bortezomib (Bor) or Carmustine (car) with High-Dose Melphalan (HDM) are Safe and Effective for Multiple Myeloma Patients (pts) Receiving a Second Autologous Stem Cell Transplant (AutoSCT)

机译：将具有高剂量蛋白酶（HDM）的替代调理方案包含硼脲（BOR）或Carmustine（轿车）对接受第二个自体干细胞移植（Autosct）的多个骨髓瘤患者（PTS）是安全可有效的

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2018年第3期|共1页
作者
Amanda N. Seddon; Anish Laul; Udit Yadav; Kathryn Schultz; John Maciejewski; Sunita Nathan;
展开▼
作者单位

Rush University Medical Center;

Rush University Medical Center;

Hematology and Oncology John H. Stroger Jr. Hospital of Cook County;

Rush University Medical Center;

Section of Bone Marrow Transplant and Cell Therapy Rush University Medical Center;

Section of Bone Marrow Transplant and Cell Therapy Rush University Medical Center;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
专利

1. Alternative Conditioning Regimens Incorporating Bortezomib (Bor) or Carmustine (car) with High-Dose Melphalan (HDM) are Safe and Effective for Multiple Myeloma Patients (pts) Receiving a Second Autologous Stem Cell Transplant (AutoSCT) [J] . Amanda N. Seddon, Anish Laul, Udit Yadav, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：将具有高剂量蛋白酶（HDM）的替代调理方案包含硼脲（BOR）或Carmustine（轿车）对接受第二个自体干细胞移植（Autosct）的多个骨髓瘤患者（PTS）是安全可有效的
2. Comparison of conditioning regimen toxicities among autologous stem cell transplantation eligible multiple myeloma patients: High-dose melphalan versus high-dose melphalan and bortezomib [J] . Aypar Eda, Izzettin Fikret Vehbi, Aki Sahika Zeynep, Journal of oncology pharmacy practice: official publication of the International Society of Oncology Pharmacy Practitioners . 2018,第4期

机译：自体干细胞移植中的调节方案毒性的比较符合多发性骨髓瘤患者：高剂量母蛋白与高剂量梅酚和硼替佐米
3. High-dose melphalan with bortezomib as conditioning regimen for autologous stem cell transplant in patients with newly diagnosed multiple myeloma who exhibited at least very good partial response to bortezomib-based induction therapy [J] . HuangW., LiJ., LiH., Leukemia and lymphoma . 2012,第12期

机译：大剂量美法仑与硼替佐米作为新诊断多发性骨髓瘤患者的自体干细胞移植条件疗法，对基于硼替佐米的诱导治疗表现出至少非常好的部分反应
4. HIGH-DOSE MELPHALAN CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN 65 PATIENTS WITH AL AMYLOIDOSIS: ORGAN PROGRESSION CAN BE DELAYED IN PATIENTS REACHING COMPLETE REMISSION [C] . SO Schonland, J.B Dengler, M Hundemer, International Symposium on Amyloidosis . 2008

机译：在65例Al淀粉样蛋白患者中，具有自体蛋白化疗的高剂量蛋白化疗：器官进展可以延迟达到完全缓解的患者
5. A Phase 1/2 Study of Ixazomib as a Replacement for Bortezomib or Carfilzomib for Multiple Myeloma Patients Recently Relapsed or Refractory to Their Last Combination Regimen Containing Either Bortezomib or Carfilzomib [D] . Forouzan, Eli. 2020

机译：Ixazomib的第1/2期作为替代品髓鞘或胭脂瘤患者的替代品的替代物，最近对含有Bortezomib或Carfilzomib的最后组合方案复发或难治
6. Busulfan Melphalan and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma [O] . Tulio E. Rodriguez, Parameswaran Hari, Patrick J. Stiff, -1

机译：白消安美法仑和硼替佐米与高剂量美法仑作为多发性骨髓瘤自体造血干细胞移植的条件治疗方案
7. Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma [O] . Rodriguez Tulio E., Hari Parameswaran, Stiff Patrick J., 2016

机译：白消安，美法仑和硼替佐米与高剂量美法仑作为多发性骨髓瘤自体造血干细胞移植的条件治疗方案

Alternative Conditioning Regimens Incorporating Bortezomib (Bor) or Carmustine (car) with High-Dose Melphalan (HDM) are Safe and Effective for Multiple Myeloma Patients (pts) Receiving a Second Autologous Stem Cell Transplant (AutoSCT)

著录项

相似文献

相关主题

期刊订阅